Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2024 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q2 2024 Earnings Call Transcript August 13, 2024

Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.21694, expectations were $-0.28.

Operator: Good day, and thank you for standing by. At this time, I would like to welcome everyone to Seres Therapeutics Second Quarter 2024 Earnings Conference Call. [Operator Instructions] I would now like to turn the conference over to Dr. Carlo Tanzi, Investor Relations. Please go ahead.

Carlo...